Daniel Arias
Stock Analyst at Stifel
(4.00)
# 375
Out of 4,829 analysts
153
Total ratings
56.67%
Success rate
423.46%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $57 → $48 | $40.26 | +19.23% | 7 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $53.90 | +11.32% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $41.66 | +44.02% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $13.00 | +7.69% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $432.59 | +43.32% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $200.83 | +29.46% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.28 | +295.60% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $9.49 | +89.67% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $5.73 | +4.71% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,174.59 | +23.45% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $62.69 | +3.68% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $53.40 | +25.47% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $366.67 | -1.82% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $115.55 | +30.68% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $42.96 | +7.89% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.12 | +371.70% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $133.72 | +54.80% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $98.50 | +11.68% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $81.57 | +145.19% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.63 | +90.11% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.93 | +241.30% | 2 | May 31, 2022 |
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $40.26
Upside: +19.23%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $53.90
Upside: +11.32%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $41.66
Upside: +44.02%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $13.00
Upside: +7.69%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $432.59
Upside: +43.32%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $200.83
Upside: +29.46%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.28
Upside: +295.60%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.49
Upside: +89.67%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $5.73
Upside: +4.71%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,174.59
Upside: +23.45%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $62.69
Upside: +3.68%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $53.40
Upside: +25.47%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $366.67
Upside: -1.82%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $115.55
Upside: +30.68%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $42.96
Upside: +7.89%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.12
Upside: +371.70%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $133.72
Upside: +54.80%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $98.50
Upside: +11.68%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $81.57
Upside: +145.19%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.63
Upside: +90.11%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.93
Upside: +241.30%